COVIXTA Trademark

Trademark Overview

On Thursday, August 13, 2020, a trademark application was filed for COVIXTA with the United States Patent and Trademark Office. The USPTO has given the COVIXTA trademark a serial number of 90112582. The federal status of this trademark filing is REGISTERED as of Tuesday, June 20, 2023. This trademark is owned by Medicago inc.. The COVIXTA trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccines
covixta

General Information

Serial Number90112582
Word MarkCOVIXTA
Filing DateThursday, August 13, 2020
Status700 - REGISTERED
Status DateTuesday, June 20, 2023
Registration Number7082850
Registration DateTuesday, June 20, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements

Goods and ServicesHuman vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMedicago inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA
Party NameMedicago inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA
Party NameMedicago inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 20, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 2, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 27, 2023ASSIGNED TO LIE
Tuesday, February 21, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 25, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 25, 2022INQUIRY TO SUSPENSION E-MAILED
Thursday, August 25, 2022SUSPENSION INQUIRY WRITTEN
Friday, February 25, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 25, 2022LETTER OF SUSPENSION E-MAILED
Friday, February 25, 2022SUSPENSION LETTER WRITTEN
Thursday, February 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 24, 2022ASSIGNED TO LIE
Tuesday, February 22, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 26, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 26, 2021INQUIRY TO SUSPENSION E-MAILED
Thursday, August 26, 2021SUSPENSION INQUIRY WRITTEN
Thursday, February 18, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 18, 2021LETTER OF SUSPENSION E-MAILED
Thursday, February 18, 2021SUSPENSION LETTER WRITTEN
Wednesday, February 17, 2021ASSIGNED TO EXAMINER
Thursday, September 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 17, 2020NEW APPLICATION ENTERED

Related Keywords

covixta vaccines human